« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 122, Issue 1
, Pages
36-41
, July 2008
Advances in basic and clinical immunology in 2007
-
The long-term follow-up of patients with severe combined immunodeficiency (SCID) who received BMT is determined by several variables at the time of treatment: age of diagnosis, degree of donor compati
The long-term follow-up of patients with severe combined immunodeficiency (SCID) who received BMT is determined by several variables at the time of treatment: age of diagnosis, degree of donor compatibility, concomitant diseases, and opportunistic infections. GvHD, Graft-versus-host disease.
Supported by National Institutes of Health Grants AI27551, AI069441, HD41983, HD052102, RR0188, HL079533, HL72705, HL78522, and RAT003084A and contract AI41089; the Pediatric Research and Education Fund, Baylor College of Medicine; and the David Fund, the Pediatrics AIDS Fund, and the Immunology Research Fund, Texas Children's Hospital.
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
PII: S0091-6749(08)00779-3
doi: 10.1016/j.jaci.2008.04.035
© 2008 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Allergy and Clinical Immunology
Volume 122, Issue 1
, Pages
36-41
, July 2008
